Met Life Investment Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$6.39 - $28.58 $62,960 - $281,598	9,853 New	9,853 $65,000
Q1 2023 May 09, 2024	BUY	$17.7 - $33.24 $174,398 - $327,513	9,853 New	9,853 $184 Million
Q1 2022 May 10, 2024	BUY	$15.0 - $22.83 $147,795 - $224,943	9,853 New	9,853 $206,000
Q1 2022 Mar 22, 2023	BUY	$15.0 - $22.83 $53,655 - $81,662	3,577 Added 56.99%	9,853 $206,000
Q1 2022 May 12, 2022	BUY	$15.0 - $22.83 $53,655 - $81,662	3,577 Added 56.99%	9,853 $206,000
Q4 2021 Jun 21, 2023	SELL	$20.12 - $35.09 $71,969 - $125,516	-3,577 Reduced 36.3%	6,276 $127,000
Q3 2021 May 17, 2024	BUY	$23.84 - $32.03 $32,231 - $43,304	1,352 Added 27.46%	6,276 $190,000
Q3 2021 Jun 21, 2023	SELL	$23.84 - $32.03 $85,275 - $114,571	-3,577 Reduced 36.3%	6,276 $190,000
Q3 2021 Mar 22, 2023	BUY	$23.84 - $32.03 $32,231 - $43,304	1,352 Added 27.46%	6,276 $190,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $32,231 - $43,304	1,352 Added 27.46%	6,276 $190,000
Q2 2021 Jun 21, 2023	SELL	$29.06 - $38.83 $143,236 - $191,393	-4,929 Reduced 50.03%	4,924 $143,000
Q1 2021 May 17, 2024	BUY	$39.04 - $64.6 $192,232 - $318,090	4,924 New	4,924 $212,000
Q1 2021 Jun 26, 2023	SELL	$39.04 - $64.6 $192,428 - $318,413	-4,929 Reduced 50.03%	4,924 $213 Million
Q4 2020 Jun 22, 2023	SELL	$42.46 - $56.58 $209,285 - $278,882	-4,929 Reduced 50.03%	4,924 $227,000
Q3 2020 Jun 26, 2023	SELL	$37.44 - $64.63 $184,541 - $318,561	-4,929 Reduced 50.03%	4,924 $213,000
Q2 2020 May 24, 2024	BUY	$17.62 - $58.71 $86,760 - $289,088	4,924 New	4,924 $261 Million
Q2 2020 Jun 26, 2023	SELL	$17.62 - $58.71 $86,848 - $289,381	-4,929 Reduced 50.03%	4,924 $261,000
Q2 2020 Mar 22, 2023	SELL	$17.62 - $58.71 $86,848 - $289,381	-4,929 Reduced 50.03%	4,924 $261,000
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $86,760 - $289,088	4,924 New	4,924 $261,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account